Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome.
Elizabeth L Berg, Stela P Petkova, Heather A Born and 3 others
PMID 34526125WHAT IT FOUND
IGF-2 did not improve motor, communication, or cognitive deficits in mouse and rat models of Angelman Syndrome.
Despite earlier reports of benefit, this study found no robust behavioral rescue and caution against assuming EEG changes translate to clinical improvement.
Key findings
01Systemic IGF-2 administration did not improve motor coordination, social communication, or learning deficits in either mouse or rat models of Angelman Syndrome.
02While IGF-2 reduced elevated delta power in EEG recordings, this physiological change did not translate to any measurable behavioral improvement.
03The study failed to replicate previous findings of IGF-2 efficacy, suggesting prior positive results may not be robust across laboratories or models.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study only tested acute, single-dose administration; chronic treatment or different dosing schedules might yield different results. The effects were limited to the specific rodent models used, which may not fully replicate human Angelman Syndrome. The discrepancy with previous positive findings highlights the difficulty of replicating behavioral effects in animal models, possibly due to methodological variations or small sample sizes in prior studies. The study did not test other IGF pathway compounds or combination therapies.
Declared interests
The research was supported by the National Institutes of Health and the Foundation for Angelman Syndrome Therapeutics. The authors did not declare commercial conflicts of interest.
The easy way to misread this
Do not assume that physiological changes in the brain, such as reduced delta power in EEG, automatically mean a patient will behave or function better. In this study, the brain signal changed, but the animals showed no improvement in movement, communication, or learning.